Gorbacheva AM, Spasskaya OY, Lavreniuk AA, Bibik EE, Tikhonov IN, Eremkina AK, Khairieva AA, Litvinova EE and Mokrysheva NG
Volume6-Issue11
Dates: Received: 2025-11-05 | Accepted: 2025-11-27 | Published: 2025-11-28
Pages: 1754-1761
Abstract
Background: Liver Cirrhosis (LC) is associated with significant bone metabolic disorders and an increased risk of fractures. While the problem is recognized, data on vitamin D metabolism and bone remodeling in patients with non-alcoholic and non-viral LC remain limited.
Aim: To conduct a comprehensive assessment of vitamin D metabolism and bone remodeling in patients with LC of non-viral and non-alcoholic etiology.
Patients and methods: A cross-sectional study included 25 patients with LC (cholestatic, autoimmune, or cryptogenic etiology) and 10 Healthy Volunteers (HV), comparable in age, sex, and BMI. All participants underwent blood sampling for analysis of vitamin D metabolites, PTH, calcium, phosphorus, bone turnover markers and IGF-1. Bone Mineral Density (BMD) was assessed by DXA, and bone microarchitecture was evaluated using the Trabecular Bone Score (TBS).
Results: Patients with LC had significantly lower levels of 25(OH)D (12.5 vs., 22.4 ng/mL, p = 0.036), PTH (26.0 vs., 37.6 pg/mL, p = 0.015), and IGF-1 (95 vs., 187 ng/mL, p = 0.010) compared to the HV group. While BMD values were comparable between groups, the TBS was significantly lower in the LC group (1.348 vs., 1.504, p = 0.004), indicating impaired bone microarchitecture. A positive correlation was found between TBS and 25(OH)D levels (R = 0.497).
Conclusion: Young patients with non-alcoholic, non-viral LC exhibit vitamin D deficiency and a lower TBS despite preserved BMD. The correlation between TBS and vitamin D underscores its potential role in bone quality. These findings highlight the need for extended diagnostics, including TBS assessment, for timely fracture risk detection in this patient population.
FullText HTML
FullText PDF
DOI: 10.37871/jbres2227
Certificate of Publication
Copyright
© 2025 Gorbacheva AM, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Gorbacheva AM, Spasskaya OY, Lavreniuk AA, Bibik EE, Tikhonov IN, Eremkina AK, Khairieva AA, Litvinova EE, Mokrysheva NG. Features of Vitamin D and Bone Metabolism in Patients with Cirrhosis of Non- Alcoholic and Non-Viral Etiology: Results of a Pilot Study. J Biomed Res Environ Sci. 2025 Nov 28; 6(11): 1756-1763. doi: 10.37871/jbres2227, Article ID: JBRES2227, Available at: https://www.jelsciences.com/articles/jbres2227.pdf
Subject area(s)
References
- Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):365-370. doi: 10.1002/cld.1061. PMID: 34136143; PMCID: PMC8177826.
- GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22. PMID: 31981519; PMCID: PMC7026710.
- Zheng JP, Miao HX, Zheng SW, Liu WL, Chen CQ, Zhong HB, Li SF, Fang YP, Sun CH. Risk factors for osteoporosis in liver cirrhosis patients measured by transient elastography. Medicine (Baltimore). 2018 May;97(20):e10645. doi: 10.1097/MD.0000000000010645. PMID: 29768330; PMCID: PMC5976349.
- Patel N, Muñoz SJ. Bone disease in cirrhosis. Clin Liver Dis (Hoboken). 2015 Oct 28;6(4):96-99. doi: 10.1002/cld.498. PMID: 31040999; PMCID: PMC6490654.
- Nakchbandi IA. Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications. World J Gastroenterol. 2014 Jul 28;20(28):9427-38. doi: 10.3748/wjg.v20.i28.9427. PMID: 25071337; PMCID: PMC4110574.
- Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019 Jan 26;393(10169):364-376. doi: 10.1016/S0140-6736(18)32112-3. PMID: 30696576.
- Arceo-Mendoza RM, Camacho PM. Postmenopausal Osteoporosis: Latest Guidelines. Endocrinol Metab Clin North Am. 2021 Jun;50(2):167-178. doi: 10.1016/j.ecl.2021.03.009. PMID: 34023036.
- Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological Management of osteoporosis in postmenopausal women: An endocrine society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221. PMID: 30907953.
- Gorbacheva AM, Bibik EE, Lavreniuk AA, Eremkina AK, Tikhonov IN, Mokrysheva NG. Mineral disorders in patients with chronic liver disease. Part 1: Epidemiology and pathophysiology. Obes Metab. 2024;21(4):373-381. doi: 10.14341/omet13124.
- Boink ABTJ, Buckley BM, Christiansen TF, Andersen NF, Külpmann WR, Lewenstam A, Maas AHJ, Plathe OM, Sachs C, Andersen OS, VanKessel AL, Zijlstra WG. IFCC recommendation on sampling, transport and storage for the determinationof the concentration of ionized calcium in whole blood, plasma and serum. J Anal Methods Chem. 1991;13(5):235-239. doi: 10.1155/S1463924691000391.
- Grzych G, Roland E, Beauvais D, Maboudou P, Lippi G. Leukocytosis interference in clinical chemistry: shall we still interpret test results without hematological data? J Med Biochem. 2019;0(0). doi: 10.2478/jomb-2019-0005.
- Orrell DH. Albumin as an aid to the interpretation of serum calcium. Clin Chim Acta. 1971 Dec;35(2):483-9. doi: 10.1016/0009-8981(71)90224-5. PMID: 5125334.
- Mamedova EO, Golounina OO, Belaya ZE. [Albumin adjustment of total serum calcium - is it worth doing?]. Probl Endokrinol (Mosk). 2024 Nov 13;70(6):45-61. Russian. doi: 10.14341/probl13503. PMID: 39868447; PMCID: PMC11775680.
- Dedov II, Melnichenko GA, Mokrysheva NG, Andreeva EN, Antsiferov MB, Beltsevich DG, Bibik EE, Gorbacheva AM, Degtyarev MV, Yeghshatyan LV, Eremkina AK, Karonova TL, Kim IV, Krupinova JA, Kryukova IV, Kuznetsov NS, Lukyanov SV, Mamedova EO, Markina NV, Mirnaya SS, Pigarova EA, Rozhinskaya LYa, Slashchuk KYu, Sleptsov IV, Chagai NB. Draft of clinical guidelines for the diagnosis and treatment of primary hyperparathyroidism in adult patients. Endocr Surg. 2023;16(4):5-54. doi: 10.14341/serg12790.
- Bilezikian JP, Khan AA, Silverberg SJ, El-Hajj Fuleihan G, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML. Evaluation and management of primary hyperparathyroidism: Summary statement and guidelines from the fifth international workshop. J Bone Miner Res. 2020;37(11):2293-2314. doi: 10.1002/jbmr.4677.
- Adamek A, Kasprzak A. Insulin-like growth factor (igf) system in liver diseases. Int J Mol Sci. 2018 Apr 27;19(5):1308. doi: 10.3390/ijms19051308. PMID: 29702590; PMCID: PMC5983723.
- Fang J, Zhang X, Chen X, Wang Z, Zheng S, Cheng Y, Liu S, Hao L. The role of insulin-like growth factor-1 in bone remodeling: A review. Int J Biol Macromol. 2023 May 31;238:124125. doi: 10.1016/j.ijbiomac.2023.124125. Epub 2023 Mar 21. PMID: 36948334.
- Corvilain J, Manderlier T, Struyven J, Fuss M, Bergans A, Nijs N, Brauman H. Metabolism of human PTH by the kidney and the liver. Horm Metab Res. 1977 May;9(3):239-42. doi: 10.1055/s-0028-1093545. PMID: 885478.
- Martin K, Hruska K, Greenwalt A, Klahr S, Slatopolsky E. Selective uptake of intact parathyroid hormone by the liver: differences between hepatic and renal uptake. J Clin Invest. 1976 Oct;58(4):781-8. doi: 10.1172/JCI108529. PMID: 965485; PMCID: PMC333239.
- Lammers WJ, van Buuren HR, Hirschfield GM, Janssen HL, Invernizzi P, Mason AL, Ponsioen CY, Floreani A, Corpechot C, Mayo MJ, Battezzati PM, Parés A, Nevens F, Burroughs AK, Kowdley KV, Trivedi PJ, Kumagi T, Cheung A, Lleo A, Imam MH, Boonstra K, Cazzagon N, Franceschet I, Poupon R, Caballeria L, Pieri G, Kanwar PS, Lindor KD, Hansen BE; Global PBC Study Group. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology. 2014 Dec;147(6):1338-49.e5; quiz e15. doi: 10.1053/j.gastro.2014.08.029. Epub 2014 Aug 23. PMID: 25160979.
- Chen R, Gong K, Chen W, Chen Z, Hua X, Tan J, Tian Y, Liu D, Zhang L, Tang Y, Li Y, Zhou S. Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018. Osteoporos Int. 2025 Feb;36(2):283-297. doi: 10.1007/s00198-024-07324-w. Epub 2024 Nov 29. PMID: 39611944.
- Klein GL, Soriano H, Shulman RJ, Levy M, Jones G, Langman CB. Hepatic osteodystrophy in chronic cholestasis: evidence for a multifactorial etiology. Pediatr Transplant. 2002 Apr;6(2):136-40. doi: 10.1034/j.1399-3046.2002.01060.x. PMID: 12000470.
- Al-Hashimi L, Klotsche J, Ohrndorf S, Gaber T, Hoff P. Trabecular bone score significantly influences treatment decisions in secondary osteoporosis. J Clin Med. 2023 Jun 20;12(12):4147. doi: 10.3390/jcm12124147. PMID: 37373840; PMCID: PMC10299520.
- Schousboe JT, Vo TN, Langsetmo L, Taylor BC, Cawthon PM, Schwartz AV, Bauer DC, Orwoll ES, Lane NE, Barrett-Connor E, Ensrud KE; Osteoporotic Fractures in Men (MrOS) Study Research Group. Association of Trabecular Bone Score (TBS) With Incident Clinical and Radiographic Vertebral Fractures Adjusted for Lumbar Spine BMD in Older Men: A Prospective Cohort Study. J Bone Miner Res. 2017 Jul;32(7):1554-1558. doi: 10.1002/jbmr.3130. Epub 2017 Apr 7. PMID: 28300346; PMCID: PMC5489355.
- Yang SW, Lin YJ, Cheng YW, Chen YY, Chen WL. Unraveling the relationship between serum 25‑hydroxyvitamin d levels and trabecular bone score in american adults. Pol Arch Intern Med. 2022 Oct 21;132(10):16311. doi: 10.20452/pamw.16311. Epub 2022 Aug 4. PMID: 35929842.
- Benetti A, Crosignani A, Varenna M, Giussani CS, Allocca M, Zuin M, Podda M, Battezzati PM. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study. J Clin Gastroenterol. 2008 Mar;42(3):306-11. doi: 10.1097/01.mcg.0000248017.31386.39. PMID: 18223492.
